These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Response of Waldenstrom's macroglobulinemia to pentostatin (2'-deoxycoformycin). Riddell S; Johnston JB; Rayner HL; Israels LG Cancer Treat Rep; 1986 Apr; 70(4):546-8. PubMed ID: 3084084 [No Abstract] [Full Text] [Related]
28. [Hairy cell leukemia successfully treated with 2'-deoxycoformycin following refractoriness to splenectomy and alpha-interferon therapy]. Shibata T; Hotta T Rinsho Ketsueki; 1992 Feb; 33(2):216-20. PubMed ID: 1635172 [TBL] [Abstract][Full Text] [Related]
29. Deoxycoformycin in therapy of refractory lymphoid neoplasms. Ho AD; Thaler J; Kuse R; Willemze R; Mandelli F; Lauria F; Zittoun R; Stryckmans P Onkologie; 1988 Feb; 11(1):35-7. PubMed ID: 3283623 [TBL] [Abstract][Full Text] [Related]
30. Deoxycoformycin-induced immunosuppression in patients with hairy cell leukemia. Urba WJ; Baseler MW; Kopp WC; Steis RG; Clark JW; Smith JW; Coggin DL; Longo DL Blood; 1989 Jan; 73(1):38-46. PubMed ID: 2783373 [TBL] [Abstract][Full Text] [Related]
31. [Successful treatment with 2'-deoxycoformycin in a case of adult T-cell leukemia]. Ishii M; Yamaguchi K; Yul LS; Oda T; Takatsuki K Rinsho Ketsueki; 1986 May; 27(5):780-3. PubMed ID: 3018324 [No Abstract] [Full Text] [Related]
32. Pentostatin in chronic lymphocytic leukemia: a phase II trial of Cancer and Leukemia group B. Dillman RO; Mick R; McIntyre OR J Clin Oncol; 1989 Apr; 7(4):433-8. PubMed ID: 2784491 [TBL] [Abstract][Full Text] [Related]
33. Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients. Maloisel F; Benboubker L; Gardembas M; Coiffier B; Divine M; Sebban C; Blanc M; Abgrall JF; Lederlin P; Harousseau JL; Blaise AM; Grosbois B; Morice P; Ghandour C; Castaigne S Leukemia; 2003 Jan; 17(1):45-51. PubMed ID: 12529659 [TBL] [Abstract][Full Text] [Related]
34. 2'-Deoxycoformycin (pentostatin) for lymphoid malignancies. Rational development of an active new drug. O'Dwyer PJ; Wagner B; Leyland-Jones B; Wittes RE; Cheson BD; Hoth DF Ann Intern Med; 1988 May; 108(5):733-43. PubMed ID: 3282467 [TBL] [Abstract][Full Text] [Related]
35. Phase I study of 2'-deoxycoformycin in acute lymphoblastic leukemia. Poplack DG; Sallan SE; Rivera G; Holcenberg J; Murphy SB; Blatt J; Lipton JM; Venner P; Glaubiger DL; Ungerleider R; Johns D Cancer Res; 1981 Sep; 41(9 Pt 1):3343-6. PubMed ID: 6973390 [TBL] [Abstract][Full Text] [Related]
36. The role of pentostatin (2'-deoxycoformycin, dCF) in the management of lymphoproliferative malignancies. Spiers AS Blood Rev; 1987 Jun; 1(2):106-10. PubMed ID: 3332090 [TBL] [Abstract][Full Text] [Related]
37. Low-dose deoxycoformycin in the treatment of hairy cell leukemia. Kraut EH; Bouroncle BA; Grever MR Blood; 1986 Nov; 68(5):1119-22. PubMed ID: 3490287 [TBL] [Abstract][Full Text] [Related]
38. [Hairy cell leukemia--a potentially curable malignancy. Selected aspects of purine analog therapy]. Rucińska M; Machaczka M; Załuska A; Skotnicki AB Przegl Lek; 1998; 55(7-8):400-6. PubMed ID: 10021885 [TBL] [Abstract][Full Text] [Related]
39. Immunohistological assessment of bone marrow biopsies from patients with hairy cell leukemia: changes following treatment with alpha-2-interferon and deoxycoformycin. Thaler J; Denz H; Dietze O; Gastl G; Ho AD; Gattringer C; Greil R; Lechleitner M; Huber C; Huber H Leuk Res; 1989; 13(5):377-83. PubMed ID: 2787447 [TBL] [Abstract][Full Text] [Related]